Nitric oxide does not inhibit but is metabolized by the cytochrome bcc-aa3 supercomplex

13Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Nitric oxide (NO) is a well-known active site ligand and inhibitor of respiratory terminal oxidases. Here, we investigated the interaction of NO with a purified chimeric bcc-aa3 supercomplex composed of Mycobacterium tuberculosis cytochrome bcc and Mycobacterium smegmatis aa3-type terminal oxidase. Strikingly, we found that the enzyme in turnover with O2 and reductants is resistant to inhibition by the ligand, being able to metabolize NO at 25◦C with an apparent turnover number as high as ≈303 mol NO (mol enzyme)−1 min−1 at 30 µM NO. The rate of NO consumption proved to be proportional to that of O2 consumption, with 2.65 ± 0.19 molecules of NO being consumed per O2 molecule by the mycobacterial bcc-aa3. The enzyme was found to metabolize the ligand even under anaerobic reducing conditions with a turnover number of 2.8 ± 0.5 mol NO (mol enzyme)−1 min−1 at 25◦C and 8.4 µM NO. These results suggest a protective role of mycobacterial bcc-aa3 supercomplexes against NO stress.

Cite

CITATION STYLE

APA

Forte, E., Giuffrè, A., Huang, L. S., Berry, E. A., & Borisov, V. B. (2020). Nitric oxide does not inhibit but is metabolized by the cytochrome bcc-aa3 supercomplex. International Journal of Molecular Sciences, 21(22), 1–12. https://doi.org/10.3390/ijms21228521

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free